MedTrace Logo

S-100B as Pre-Head CT Scan Screening Test After Mild Traumatic Brain Injury

NCT00717301 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1252

Last updated 2015-06-12

No results posted yet for this study

Summary

The purpose of the study is to determine if a specific blood protein, S-100B, can help predict who will have a traumatic abnormality on head CT scan after a concussion. We will compare the levels of this protein in the subject's blood to the initial head CT scan and to how the subject is feeling one month after injury. We hope that the information we collect in this trial will help us determine who needs a head CT scan after a concussion and who may be more likely to have trouble recovering from a concussion.

Conditions

Sponsors & Collaborators

  • Academic Health Center Consortium (not Univ of Minnesota)

    collaborator UNKNOWN

  • New York State Department of Health

    collaborator OTHER_GOV

  • Emergency Research Network of the Empire State

    collaborator UNKNOWN

  • University of Rochester

    lead OTHER

Principal Investigators

  • Jeffrey J Bazarian, MD, MPH · University of Rochester

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2010-09-30
Completion
2010-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00717301 on ClinicalTrials.gov